Literature DB >> 24504023

Dual regulation of SPI1/PU.1 transcription factor by heat shock factor 1 (HSF1) during macrophage differentiation of monocytes.

G Jego1, D Lanneau1, A De Thonel1, K Berthenet1, A Hazoumé1, N Droin2, A Hamman1, F Girodon1, P-S Bellaye1, G Wettstein1, A Jacquel3, L Duplomb4, A Le Mouël5, C Papanayotou6, E Christians7, P Bonniaud1, V Lallemand-Mezger5, E Solary2, C Garrido8.   

Abstract

In addition to their cytoprotective role in stressful conditions, heat shock proteins (HSPs) are involved in specific differentiation pathways, for example, we have identified a role for HSP90 in macrophage differentiation of human peripheral blood monocytes that are exposed to macrophage colony-stimulating factor (M-CSF). Here, we show that deletion of the main transcription factor involved in heat shock gene regulation, heat shock factor 1 (HSF1), affects M-CSF-driven differentiation of mouse bone marrow cells. HSF1 transiently accumulates in the nucleus of human monocytes undergoing macrophage differentiation, including M-CSF-treated peripheral blood monocytes and phorbol ester-treated THP1 cells. We demonstrate that HSF1 has a dual effect on SPI1/PU.1, a transcription factor essential for macrophage differentiation and whose deregulation can lead to the development of leukemias and lymphomas. Firstly, HSF1 regulates SPI1/PU.1 gene expression through its binding to a heat shock element within the intron 2 of this gene. Furthermore, downregulation or inhibition of HSF1 impaired both SPI1/PU.1-targeted gene transcription and macrophage differentiation. Secondly, HSF1 induces the expression of HSP70 that interacts with SPI1/PU.1 to protect the transcription factor from proteasomal degradation. Taken together, HSF1 appears as a fine-tuning regulator of SPI1/PU.1 expression at the transcriptional and post-translational levels during macrophage differentiation of monocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24504023     DOI: 10.1038/leu.2014.63

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  35 in total

1.  Defective nuclear localization of Hsp70 is associated with dyserythropoiesis and GATA-1 cleavage in myelodysplastic syndromes.

Authors:  Emilie Frisan; Julie Vandekerckhove; Aurélie de Thonel; Cécile Pierre-Eugène; Alexander Sternberg; Jean-Benoît Arlet; Célia Floquet; Emmanuel Gyan; Olivier Kosmider; François Dreyfus; Anne-Sophie Gabet; Geneviève Courtois; Paresh Vyas; Jean-Antoine Ribeil; Yael Zermati; Catherine Lacombe; Patrick Mayeux; Eric Solary; Carmen Garrido; Olivier Hermine; Michaela Fontenay
Journal:  Blood       Date:  2011-12-12       Impact factor: 22.113

Review 2.  Dual role of heat shock proteins as regulators of apoptosis and innate immunity.

Authors:  Anne-Laure Joly; Guillaume Wettstein; Gregoire Mignot; François Ghiringhelli; Carmen Garrido
Journal:  J Innate Immun       Date:  2010-03-16       Impact factor: 7.349

3.  Genome-wide analysis of human HSF1 signaling reveals a transcriptional program linked to cellular adaptation and survival.

Authors:  Todd J Page; Devanjan Sikder; Longlong Yang; Linda Pluta; Russell D Wolfinger; Thomas Kodadek; Russell S Thomas
Journal:  Mol Biosyst       Date:  2006-06-23

4.  Unusual levels of heat shock element-binding activity in embryonal carcinoma cells.

Authors:  V Mezger; O Bensaude; M Morange
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

5.  HSP27 controls GATA-1 protein level during erythroid cell differentiation.

Authors:  Aurelie de Thonel; Julie Vandekerckhove; David Lanneau; Subramaniam Selvakumar; Geneviève Courtois; Adonis Hazoume; Mathilde Brunet; Sebastien Maurel; Arlette Hammann; Jean Antoine Ribeil; Yael Zermati; Anne Sophie Gabet; Joan Boyes; Eric Solary; Olivier Hermine; Carmen Garrido
Journal:  Blood       Date:  2010-04-21       Impact factor: 22.113

6.  Two distinct auto-regulatory loops operate at the PU.1 locus in B cells and myeloid cells.

Authors:  Mathias Leddin; Chiara Perrod; Maarten Hoogenkamp; Saeed Ghani; Salam Assi; Sven Heinz; Nicola K Wilson; George Follows; Jörg Schönheit; Lena Vockentanz; Ali M Mosammam; Wei Chen; Daniel G Tenen; David R Westhead; Berthold Göttgens; Constanze Bonifer; Frank Rosenbauer
Journal:  Blood       Date:  2011-01-14       Impact factor: 22.113

7.  PU.1 is regulated by NF-kappaB through a novel binding site in a 17 kb upstream enhancer element.

Authors:  N Bonadies; Ch Neururer; A Steege; S Vallabhapurapu; T Pabst; B U Mueller
Journal:  Oncogene       Date:  2009-12-07       Impact factor: 9.867

8.  Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1.

Authors:  Frank Rosenbauer; Katharina Wagner; Jeffery L Kutok; Hiromi Iwasaki; Michelle M Le Beau; Yutaka Okuno; Koichi Akashi; Steven Fiering; Daniel G Tenen
Journal:  Nat Genet       Date:  2004-05-16       Impact factor: 38.330

9.  Down-regulation of PU.1 by methylation of distal regulatory elements and the promoter is required for myeloma cell growth.

Authors:  Hiro Tatetsu; Shikiko Ueno; Hiroyuki Hata; Yasuhiro Yamada; Motohiro Takeya; Hiroaki Mitsuya; Daniel G Tenen; Yutaka Okuno
Journal:  Cancer Res       Date:  2007-06-01       Impact factor: 12.701

10.  HSF1 drives a transcriptional program distinct from heat shock to support highly malignant human cancers.

Authors:  Marc L Mendillo; Sandro Santagata; Martina Koeva; George W Bell; Rong Hu; Rulla M Tamimi; Ernest Fraenkel; Tan A Ince; Luke Whitesell; Susan Lindquist
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

View more
  17 in total

1.  Heat shock in the springtime.

Authors:  Kevin A Morano; Lea Sistonen; Valérie Mezger
Journal:  Cell Stress Chaperones       Date:  2014-09-09       Impact factor: 3.667

2.  Nuclear ERK5 inhibits progression of leukemic monocytes to macrophages by regulating the transcription factor PU.1 and heat shock protein HSP70.

Authors:  Ruifang Zheng; George P Studzinski
Journal:  Leuk Lymphoma       Date:  2016-10-17

3.  HSP110 promotes colorectal cancer growth through STAT3 activation.

Authors:  K Berthenet; A'dem Bokhari; A Lagrange; G Marcion; C Boudesco; S Causse; A De Thonel; M Svrcek; A R Goloudina; S Dumont; A Hammann; D S Biard; O N Demidov; R Seigneuric; A Duval; A Collura; G Jego; C Garrido
Journal:  Oncogene       Date:  2016-11-07       Impact factor: 9.867

Review 4.  IL-32θ: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity.

Authors:  Muhammad Babar Khawar; Maryam Mukhtar; Muddasir Hassan Abbasi; Nadeem Sheikh
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

Review 5.  Roles of heat shock factor 1 beyond the heat shock response.

Authors:  János Barna; Péter Csermely; Tibor Vellai
Journal:  Cell Mol Life Sci       Date:  2018-05-17       Impact factor: 9.261

Review 6.  HSF1 as a Cancer Biomarker and Therapeutic Target.

Authors:  Richard L Carpenter; Yesim Gökmen-Polar
Journal:  Curr Cancer Drug Targets       Date:  2019       Impact factor: 3.428

7.  A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.

Authors:  Brigette Boast; Lisa A Miosge; Hye Sun Kuehn; Vicky Cho; Vicki Athanasopoulos; Hayley A McNamara; Yovina Sontani; Yan Mei; Debbie Howard; Henry J Sutton; Sofia A Omari; Zhijia Yu; Mariam Nasreen; T Daniel Andrews; Ian A Cockburn; Christopher C Goodnow; Sergio D Rosenzweig; Anselm Enders
Journal:  J Immunol       Date:  2021-03-03       Impact factor: 5.422

8.  IL-32θ inhibits monocytic differentiation of leukemia cells by attenuating expression of transcription factor PU.1.

Authors:  Man Sub Kim; Jeong-Woo Kang; Yun Sun Park; Dong Hun Lee; Yesol Bak; Taeho Kwon; Do-Young Yoon
Journal:  Oncotarget       Date:  2015-02-28

9.  Requirement for endogenous heat shock factor 1 in inducible nitric oxide synthase induction in murine microglia.

Authors:  Chao Huang; Xu Lu; Lijuan Tong; Jili Wang; Wei Zhang; Bo Jiang; Rongrong Yang
Journal:  J Neuroinflammation       Date:  2015-10-14       Impact factor: 8.322

10.  Selective Inhibition of JAK1 Primes STAT5-Driven Human Leukemia Cells for ATRA-Induced Differentiation.

Authors:  Haley E Ramsey; Kristy Stengel; James C Pino; Gretchen Johnston; Merrida Childress; Agnieszka E Gorska; Pia M Arrate; Londa Fuller; Matthew Villaume; Melissa A Fischer; P Brent Ferrell; Caroline E Roe; Jing Zou; Alexander L R Lubbock; Matthew Stubbs; Sandra Zinkel; Jonathan M Irish; Carlos F Lopez; Scott Hiebert; Michael R Savona
Journal:  Target Oncol       Date:  2021-07-29       Impact factor: 4.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.